Albert Bourla, Pfizer CEO (AP Images)
February 8, 2022 08:54 AM EST
Coronavirus

Pfiz­er's Covid-19 vac­cine cap­tures the most an­nu­al sales of any med­ical prod­uct ever — by more than $15B

Zachary Brennan

Senior Editor

As Pfiz­er now con­trols about 70% of the Covid-19 vac­cine mar­ket in the US and Eu­rope, the com­pa­ny an­nounced Tues­day a gar­gan­tu­an to­tal of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

No­vo and Viking present new MASH da­ta, but an­a­lysts re­main con­fi­dent in Madri­gal's Rezd­if­fra

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times